References
- Xue K, Yang J, Hu J, et al. MicorRNA-133b expression associates with clinicopathological features and prognosis in glioma. Artif Cells Nanomed Biotechnol. 2017;6:1–4.
- Xu Y, Xu W, Lu T, et al. miR-126 affects the invasion and migration of glioma cells through GATA4. Artif Cells Nanomed Biotechnol. 2016;6:1247–1253.
- Attwell D, Buchan AM, Charpak S, et al. Glial and neuronal control of brain blood flow. Nature. 2010;468:232–243.
- Baker GJ, Yadav VN, Motsch S, et al. Mechanisms of glioma formation: iterative perivascular glioma growth and invasion leads to tumor progression, VEGF-independent vascularization, and resistance to antiangiogenic therapy. Neoplasia. 2014;16:543–561.
- Basş M, Greve J, Stelter K, et al. A randomized trial of icatibant in ACE-inhibitor-induced angioedema. N Engl J Med. 2015;372:418–425.
- Bazargani N, Attwell D. Astrocyte calcium signaling: the third wave. Nat Neurosci. 2016;19:182–189.
- Thorin E, Clozel M. The cardiovascular physiology and pharmacology of endothelin-1. Adv Pharmacol. 2010;60:1–26.
- Khimji AK, Rockey DC. Endothelin-biology and disease. Cell Signal. 2010;22:1615–1625.
- Seccia TM, Calo LA. Endothelin-1-induced endothelial mesenchymal transition via endothelin type B receptor stimulation: implication for chronic kidney disease. J Hypertens. 2017;35:1329–1330.
- Koehl B, Nivoit P, El Nemer W, et al. The endothelin B receptor plays a crucial role for the adhesion of neutrophils to the endothelium in sickle cell of disease. Haematologica. 2017;102:1161–1172.
- Becker BK, Speed JS, Powell M, et al. Activation of neuronal endothelin B receptors mediates pressor response through alpha-1 adrenergic receptors. Physiol Rep. 2017;5:e13077.
- Au M, Zhu M, Chang WJ, et al. Emerging role of endothelin receptor type B in regulating chondrogenic and hypertrophic changes of human mesenchymal stem cells. Osteoarthritis Cartilage. 2017;25:S423–S424.
- Meidan R, Levy N. The ovarian endothelin network: an evolving story. Trends Endocrinol Metab. 2007;18:379–385.
- Griswold DE, Douglas SA, Martin LD, et al. Endothelin B receptor modulates inflammatory pain and cutaneous inflammation. Mol Pharmacol. 1999;56:807–812.
- Salani D, Taraboletti G, Rosanò L, et al. Endothelin-1 induces an angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. Am J Pathol. 2000;157:1703–1711.
- Bouffet E, Tabori U, Huang A, et al. Possibilities of new therapeutic strategies in brain tumors. Cancer Treat Rev. 2010;36:335–341.
- Binder C, Hagemann T, Sperling S, et al. Stromal endothelin B receptor-deficiency inhibits breast cancer growth and metastasis. Mol Cancer Ther. 2009;8:2452–2460.
- Brunner F, Brás-Silva C, Cerdeira AS, et al. Cardiovascular endothelins: essential regulators of cardiovascular homeostasis. Pharmacol Ther. 2006;111:508–531.
- Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol. 2009;9:162–174.
- Mansh M. Ipilimumab and cancer immunotherapy: a new hope for advanced stage melanoma. Yale J Biol Med. 2011;84:381–389.
- Shi Y, Massague J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell. 2003;113:685–700.
- Zhang K, Zhang J, Han L, et al. Wnt/beta-catenin signaling in glioma. J Neuroimmune Pharmacol. 2012;7:740–749.